You have 9 free searches left this month | for more free features.

Condition

MTAP-null Non-Small-Cell Lung Cancer (1)

MTAP-null Solid Tumors (1)

Solid Tumor (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Amgen (1)

IDEAYA Biosciences (1)

Collaborator

Intervention

ide397 (2)

amg 193 (1)

docetaxel (1)

gemcitabine (1)

nab paclitaxel (1)

paclitaxel (1)

pemetrexed (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ide397

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

Not yet recruiting

MTAP-null Non-Small-Cell Lung Cancer
MTAP-null Solid Tumors

AMG 193
IDE397

(no location specified)

Jul 27, 2023

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting

Solid Tumor

IDE397
+5 more

Scottsdale, Arizona
+10 more

Jul 20, 2022